Family therapeutic FMF is a dubious disease in the field of autoimmunity and rheumatic immunity, clinical performance is complex and often involves multiple systemic burdens. Early identification and standardised clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of family therapeutic FMF requires individualized development, typically including multidimensional management, such as drug therapy, rehabilitation, and regular follow-up. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune disorders that were previously difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely schemes depending on the changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of family-specific Mediterranean hot FMFs. The platform serves a team of internationally authoritative experts in the field of self-immunity and rheumatic immunity in China.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.